Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ATRenew Sees Q3 Sales $704.953M-$718.912M vs $725.000M Est

Author: Benzinga Newsdesk | August 20, 2025 06:21am

ATRenew (NYSE:RERE) sees Q3 sales of $704.953 million-$718.912 million vs $725.000 million analyst estimate.

Posted In: RERE